Navigation Links
Mathematical Bio-Solutions Inc. Named 2009 Top 50 Emerging Company in FundgPost's 6th Annual Pitching Across America
Date:10/29/2009

MB-Solutions is a developer and manufacturer of next generation of non-invasive diagnostic and therapeutic medical devices, utilizing patent-pending pulsed magnetic flux-field technologies to treat two pervasive medical ailments: (1) chronic and acute pain, and (2) heart disease.

New York (PRWEB) October 29, 2009 -- Mathematical Bio-Solutions Inc. (MB-Solutions) announced today that it has been selected in FundingPost's 6th annual Pitch Across America Competition as one of the Top 50 Emerging Companies of the FundingPost's Pitching Across America contest.

"We are proud to have MB-Solutions as one of this year's winners." said Joe Rubin, Director, FundingPost. "They have a quality product, led by a hard working and experienced management team. It's easy to see how they were chosen by our judges!"

MB-Solutions is a developer and manufacturer of next generation of non-invasive diagnostic and therapeutic medical devices, utilizing patent-pending pulsed magnetic flux-field technologies to treat two pervasive medical ailments. The initial such device, the Non-Invasive Pain Eliminator (NPE)TM provides long-term and permanent pain reduction and elimination. The NPE has clinically-proven effectiveness in curing various forms of chronic pain -- including arthritis -- injury-based and post-operative pain. The NPE pulsed magnetic field treatment method is a safe and effective non-invasive, alternative to pharmaceutical and surgical approaches to pain management, without risk of habituation or other adverse side effects.

"We are honored that FundingPost has named MB-Solutions as among the Top 50 emerging companies of Pitching Across America. As an early stage company, it's great to be so favorably recognized by a national panel of angel and venture capital investors. It certainly contributes additional validity to our business model and NPE technologies"--Steven Turner, Co-Founder of MB-Solutions

The next planned MB-Solutions device will similarly utilize pulsed magnetic field technologies, to address yet another pervasive medical ailment, heart disease: a completely External Cardiac Rhythm Normalizer (ECN)TM pacemaker. Successfully completed Phase I clinical trials confirm the potential of the ECN, once commercially-deployed emerging as a viable, cost-effective--and safer - alternative to surgically implanted pacemakers and defibrillators currently in use.

About FundingPost-With over 9,500 CEOs and 620 Venture Capital Funds attending events in 18 cities nationwide; a Printed Dealflow Magazine; and a deal-exchange website with over 7,500 VC & Angel Investor members & over 110,000 companies, that has, on average, made an introduction of an Investor to an Entrepreneur every business day since its inception; FundingPost believes that it is important to reach investors in every medium possible - both online and offline. FundingPost has been responsible for Millions and Millions of dollars in Venture Capital Raised! http://www.fundingpost.com

Contact: Steven M. Turner
646-275-9408
135 W. 16th Street, Suite 11
New York, NY 10011

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3027864.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. New mathematical model more accurately diagnoses acute heart failure in emergency rooms
2. Mathematical modeling predicts response to Herceptin
3. Scientists develop mathematical model to predict the immune response to influenza
4. Mathematical models of adaptive immunity
5. Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
6. Mathematical modeling offers new approaches to fight dual-resistant hospital infections
7. A new mathematical formula for cancer progression
8. Warady & Davis LLP Named One of 'Top 50 Employers for Generation Y Chicago'
9. Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest Growing Companies
10. Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm
11. Dr. Lawrence Brown Named President of the Child Neurology Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of a pioneering ... , the largest Electronic Medical Records (EMR) provider in South Africa. By using ... a patient’s remote health progress, empowering the patient to take direct responsibility for their ...
(Date:4/26/2017)... Jersey City, NJ (PRWEB) , ... April 26, 2017 , ... ... that offers an easy way to get nutrients from SUPERFOODS! , RawTrition ... the body at the cellular level because the body recognizes its raw form (unlike ...
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical ... devices are tubes used to remove excess liquid and ... serum, pus, urine, bile or lymph. Surgical drains are ... surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic ... prophylactic post-surgery to prevent accumulation of fluid e.g. blood ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: